Cost per responder of biologic drugs used in the treatment of moderate-to-severe plaque psoriasis in France and Germany
{{output}}
Objective: The treatment of moderate-to-severe plaque psoriasis has seen significant improvements in recent years with the advent of biologic drugs. The aim of this study was to assess the cost-effectiveness of anti-IL17 drugs an... ...
